Pbs Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Pbs Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2018-10-24 Varanasi, Uttar Pradesh Active Unlisted
Share
Connect MCP
PL Pbs Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pbs Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Pbs Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 80/100. Pbs Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Healthcare sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. Pbs Life Sciences Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (23.55 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 2 auditor resignation(s) filed - latest: S. Chawdhary & Associates on 2023-04-17.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHA SINGH 01234567 Director 01/04/2018 6 yrs Approved
PRASHANT KUMAR SINGH 01234567 Director 01/04/2018 6 yrs Approved
PRATAP BAHADUR SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • PRATAP BAHADUR SINGH has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 7 years.
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment80/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 23.55 cr already registered.
  • Compliance record supports lending.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 11 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
04 Mar 2023
Charge created
Others - 23.55 cr
10 Dec 2022
Securities allotted
400000 Equity Shares - 40.00 Lakh raised
25 Mar 2022
Securities allotted
160000 Equity Shares - 16.00 Lakh raised
20 Jan 2022
Securities allotted
2240000 Equity Shares - 2.24 cr raised
16 Sep 2021
Securities allotted
1200000 Equity Shares - 1.20 cr raised
01 Jul 2021
Director appointed
PRATAP BAHADUR SINGH (Director)
24 Oct 2018
Incorporated
Registered with Roc Kanpur
Director appointed
ASHA SINGH (Director)
Director appointed
PRASHANT KUMAR SINGH (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Gatha Welfare Foundation U85320UP2018NPL101015 Varanasi, Uttar Pradesh
Lokeshvara Realassociates Private Limited U09900UP2024PTC197506 Varanasi, Uttar Pradesh
R.K. Infratech Private Limited U74120UP2012PTC049269 Varanasi, Uttar Pradesh
Jjmk Projects Private Limited U45309UP2021PTC153529 Varanasi, Uttar Pradesh
Maruti Nandan Security Services Private Limited U74999UP2022PTC161439 Varanasi, Uttar Pradesh
Norps Medtech Private Limited U51909UP2021PTC157206 Varanasi, Uttar Pradesh
Shristhi Bhumi Infrastructure Private Limited U70102UP2015PTC072049 Varanasi, Uttar Pradesh
Ripe Aviation Private Limited U51102UP2018PTC102340 Varanasi, Uttar Pradesh
Rocklane Infrastructures Private Limited U70100UP2014PTC061794 Varanasi, Uttar Pradesh
AMELIORATE AUTOMOBILES PRIVATE LIMITED U50500UP2017PTC096553 Varanasi, Uttar Pradesh
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pbs Life Sciences Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pbs Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Pbs Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Pbs Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Pbs Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pbs Life Sciences Private Limited an active company?

Pbs Life Sciences Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Pbs Life Sciences Private Limited financially healthy?

Pbs Life Sciences Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Pbs Life Sciences Private Limited?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pbs Life Sciences Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Pbs Life Sciences Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Pbs Life Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Pbs Life Sciences Private Limited?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.